Advertisement

Hemofiltration pp 233-251 | Cite as

Continuous Arteriovenous Hemofiltration

  • J. P. Bosch
Chapter

Abstract

Continuous arteriovenous hemofiltration (CAVH) is an extracorporeal process in which fluid, electrolytes, small and medium-sized molecules (molecular weight less than 50 000) are removed from the patient by ultrafiltration over an extended period (hours or days). Simultaneously, the blood volume is reconstituted by the administration of a fluid with an electrolyte composition similar to that of normal plasma. A small filter with a membrane highly permeable to water is used in this procedure. The patient’s arterial-to-venous pressure gradient is usually sufficient to move the blood through the extracorporeal circuit.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Silverstein ME, Ford CA, Lysaght MJ, Henderson LW (1974) The treatment of intractable fluid overload. N Engl J Med 291: 747PubMedCrossRefGoogle Scholar
  2. 2.
    Henderson L, Besarab A, Michaels A, Bluemle LW Jr (1967) Blood purification by ultrafiltration and fluid replacement (diaflltration). Trans Am Soc Artif Intern Organs 13: 216Google Scholar
  3. 3.
    Kramer P, Wigger W, Rieger J, Matthaei D, Scheler F (1977) Arteriovenous haemofiltration: a new and simple method for treatment of over-hydrated patients resistant to diuretics. Klin Wochenschr 55: 1121PubMedCrossRefGoogle Scholar
  4. 4.
    Synhaivsky A, Kurtz SB, Wochos DN, Schniepp J, Johnson WJ (1983) Acute renal failure treated by slow continuous ultrafiltration. Mayo Clin Proc 58: 729PubMedGoogle Scholar
  5. 5.
    Kramer P, Kaufhold C, Grone HJ, Wigger W, Rieger D (1980) Management of anuric intensive-care patients with arteriovenous hemofiltration. Int J Artif Organs 3: 225PubMedGoogle Scholar
  6. 6.
    Göhl H, Konstantin P, Gulberg CA (1982) Hemofiltration membranes. Contrib Nephrol 32: 20PubMedGoogle Scholar
  7. 7.
    Lieberman KV, Nardi L, Bosch JP (1985) Treatment on an infant with acute renal failure using continuous arteriovenous hemofiltration. J Pediatr (In press)Google Scholar
  8. 8.
    Lauer A, Saccaggi A, Ronco C, Belledonne M, Glabman S, Bosch JP (1983) Continuous arterivenous hemofiltration in the critically ill patient. Ann Intern Med 99: 455PubMedCrossRefGoogle Scholar
  9. 9.
    Chang RL, Ueki IF, Troy JL, Deen WM, Robertson CR, Brenner BM (1975) Permselectivity of the capillary wall to macromolecules. II. Experimental studies in rat using neutral dextran. Biophys J 15: 887PubMedCentralPubMedCrossRefGoogle Scholar
  10. 10.
    Kaplan AA, Longnecker RE, Folkert VW (1984) Continuous arteriovenous hemofiltration: a report of six months’ experience. Ann Intern Med 100: 359CrossRefGoogle Scholar
  11. 11.
    Geronemus R, von Albertini B, Glabman S, Lysaght M, Kahn T, Bosch JP (1978) Enhanced molecular clearance in hemofiltration. Proc Clin Dial Transplant Forum 8: 147PubMedGoogle Scholar
  12. 12.
    Kaplan AA, Longnecker RE, Folkert VW (1983) Suction-assisted continuous arteriovenous hemofiltration. Trans Am Soc Artif Intern Organs 29: 408PubMedGoogle Scholar
  13. 13.
    Geronemus R, Schneider W (1984) Continuous arteriovenous hemodialysis: a new modality for treatment of acute renal failure. Trans Am Soc Artif Intern Organs 30: 423Google Scholar
  14. 14.
    Paganini EP, Nakamoto S (1980) Continuous slow ultrafiltration in oliguric acute renal failure. Trans Am Soc Artif Intern Organs 26: 201PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1986

Authors and Affiliations

  • J. P. Bosch

There are no affiliations available

Personalised recommendations